Patent · US Active

Purification method

US9346771B2 · kind B2 · utility

2Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 11, 2015
Grant dateMay 24, 2016
Priority date
Expiry dateFeb 11, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/05
  • WIPO fieldChemical engineering
  • WIPO sectorChemistry

Abstract

A diagnostic imaging agent useful for positron emission tomography (PET) imaging as well as to improved hardware for producing such imaging agents is described. Flutemetamol (18F) Injection for the imaging of β-amyloid plaques in the brain and methods and devices for preparing same are described including the automated synthesis and purification of [18F]flutemetamol by means of solid phase extraction (SPE).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.